Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 4, 2023Diabetes CareOpen Access

Occurrence of Gastrointestinal Adverse Events Upon GLP-1 Receptor Agonist Initiation With Concomitant Metformin Use: A Post Hoc Analysis of LEADER, STEP 2, SUSTAIN-6, and PIONEER 6

View Full Paper
Ask AI
Bookmark
Share

Authors

KKKlara R. KleinUniversity of North Carolina at Chapel HillKCKim Katrine Bjerring ClemmensenSteno Diabetes CentersEFEdwin FongUniversity of Hong Kong

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Klein et al. (2023) studied this question.

synapsesocial.com/papers/6a02a54e1abe013fb89e2521https://doi.org/10.2337/dc23-1791
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes2016 · 7,654 citations
  2. 2Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes2017 · 223 citations
  3. 39. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—20212020 · 987 citations
  4. 4Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice2021 · 228 citations
  5. 5Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes2019 · 2,014 citations